Recombinant Escherichia coli GMP synthase [glutamine-hydrolyzing] (guaA)

What is the biochemical function of E. coli GMP synthetase?

E. coli GMP synthetase (GMPS) catalyzes the amination of xanthosine 5′monophosphate (XMP) to yield guanosine monophosphate (GMP), utilizing glutamine and ATP in a reaction that proceeds through an adenyl-XMP (AMP-XMP) intermediate . This enzyme is crucial for the de novo biosynthesis pathway of guanine nucleotides, with GMP serving as a precursor to GTP that supports key cellular processes including DNA replication, transcription, and translation .

GMPS belongs to the glutamine amidotransferase (GAT) family and contains two distinct catalytic domains:

• The glutaminase domain (GATase) for glutamine hydrolysis

• The ATP pyrophosphatase domain (ATPPase) for the formation of GMP

The reaction can be summarized as:
XMP + ATP + Glutamine → GMP + AMP + PPi + Glutamate

What are the optimal conditions for expressing recombinant E. coli GMP synthetase?

For optimal expression of recombinant E. coli GMPS:

• Clone the E. coli guaA gene into a tac expression vector system, which provides strong and controllable expression .

• Transform the construct into an appropriate E. coli expression strain (typically BL21(DE3) or its derivatives).

• Grow cultures at 37°C until mid-log phase (OD600 of 0.6-0.8).

• Induce expression with IPTG (typically 0.5-1.0 mM) for 3-4 hours at 30°C.

• Harvest cells by centrifugation and store cell pellets at -80°C until purification.

This approach has been successfully used to generate sufficient quantities of functional GMPS for crystallographic studies . For proteins destined for structural studies, lowering the induction temperature to 18-25°C can sometimes improve solubility.

What purification strategy is most effective for recombinant E. coli GMPS?

A multi-step purification strategy is recommended for obtaining high-purity recombinant E. coli GMPS:

• Cell lysis: Resuspend cell pellets in a buffer containing 50 mM Tris-HCl (pH 7.5-8.0), 150-300 mM NaCl, 5-10 mM β-mercaptoethanol or DTT, and protease inhibitor cocktail. Lyse cells by sonication or French press.

• Initial capture: Apply the clarified lysate to an affinity column if the construct contains a tag (His-tag, GST, etc.) or use ion exchange chromatography (typically DEAE or Q-Sepharose).

• Intermediate purification: Perform ammonium sulfate fractionation followed by hydrophobic interaction chromatography.

• Polishing step: Use size exclusion chromatography (Superdex 200) to obtain pure protein and confirm the dimeric state of the enzyme in solution .

The final purified protein should be concentrated to 10-15 mg/mL for crystallization studies or stored at -80°C in a buffer containing 20-25% glycerol for enzymatic assays.

How can the enzymatic activity of recombinant E. coli GMPS be measured?

Several complementary approaches can be used to assay GMPS activity:

• Coupled spectrophotometric assay: Measure the rate of glutamine-dependent or NH4+-dependent GMP formation by coupling the reaction to the oxidation of NADH, monitoring absorbance decrease at 340 nm.

• HPLC-based assay: Quantify the conversion of XMP to GMP by separating the nucleotides on a C18 reverse-phase column and monitoring absorbance at 254 nm.

• Pyrophosphate release assay: Measure the release of pyrophosphate (PPi) using a coupled enzymatic assay with pyrophosphatase and a colorimetric detection of inorganic phosphate.

• Glutamate detection assay: Quantify the glutamate produced during the glutaminolysis reaction using glutamate dehydrogenase and NAD+, monitoring absorbance increase at 340 nm.

Each of these assays provides different information about the catalytic properties of GMPS, and researchers should select the appropriate method based on the specific aspect of enzyme function being investigated.

What are the optimal conditions for crystallizing recombinant E. coli GMPS for X-ray diffraction studies?

Based on successful crystallization experiments, the following conditions are recommended for obtaining diffraction-quality crystals of E. coli GMPS:

• Prepare purified GMPS at 10-15 mg/mL in a buffer containing 20 mM Tris-HCl (pH 7.5), 50-100 mM NaCl, and 1-2 mM DTT.

• Add ligands to stabilize the enzyme in an active conformation:

  • 5-10 mM MgCl2

  • 2-5 mM ATP

  • 2-5 mM XMP

• Set up crystallization trials using the hanging drop vapor diffusion method, mixing equal volumes of protein solution and reservoir solution.

• Optimal crystallization conditions that yielded monoclinic crystals include:

  • Temperature: 20°C

  • Crystal morphology: Monoclinic, space group P2(1)

  • Unit cell parameters: a = 156.0 Å, b = 102.0 Å, c = 78.8 Å, β = 96.7°

• For phase determination, crystals can be derivatized with p-chloromercuribenzylsulfonic acid (PCMBS) for multi-wavelength anomalous diffraction (MAD) experiments .

How does the quaternary structure of E. coli GMPS differ between solution and crystal states?

An intriguing aspect of E. coli GMPS structural biology is the discrepancy between its oligomeric states in solution versus crystalline form:

• Solution state: E. coli GMPS exists predominantly as a dimer in solution, as determined by size exclusion chromatography and analytical ultracentrifugation .

• Crystal state: X-ray crystallographic studies revealed that the enzyme forms a tetramer with D2 symmetry in the crystallographic asymmetric unit .

This difference suggests that:

• Crystal packing forces may stabilize a tetrameric assembly

• The enzyme might exist in a dynamic equilibrium between dimeric and tetrameric states

• The tetrameric form could represent a functional state relevant under specific cellular conditions

Researchers investigating GMPS should be aware of this discrepancy and consider how it might affect interpretations of structure-function relationships. Experimental approaches like crosslinking, native mass spectrometry, or small-angle X-ray scattering (SAXS) could help clarify the physiologically relevant oligomeric state.

What is the molecular mechanism of ammonia channeling in E. coli GMPS?

E. coli GMPS, like other glutamine amidotransferases, features an intramolecular tunnel that channels ammonia between its two catalytic sites:

• Ammonia generation: The GATase domain hydrolyzes glutamine to produce glutamate and ammonia.

• Ammonia transfer: The generated ammonia travels approximately 20-30 Å through a hydrophobic tunnel to reach the ATPPase active site.

• Ammonia utilization: At the ATPPase site, ammonia performs a nucleophilic attack on the adenyl-XMP intermediate to form GMP .

Evidence for ammonia channeling in GMPS includes:

• Stoichiometric hydrolysis of ATP to AMP and inorganic pyrophosphate paired with glutamine conversion to glutamate

• 15N-edited proton NMR spectroscopy demonstrating that ammonia released from glutamine is not equilibrated with the external medium

• The observation that glutamine-dependent GMP formation is optimal when the ratio of GATase to ATPPase is 1:1

This channeling mechanism serves to protect the reactive ammonia intermediate from the cellular environment and ensures efficient coupling between the two catalytic reactions.

What key active site residues are essential for E. coli GMPS catalytic function?

Based on structural and functional studies, several critical residues in E. coli GMPS have been identified that are essential for its catalytic activity:

GATase domain:

• The catalytic triad (Cys-His-Glu) responsible for glutamine hydrolysis

• Residues forming the oxyanion hole that stabilizes the tetrahedral intermediate during glutamine hydrolysis

ATPPase domain:

• Residues coordinating ATP- Mg2+ binding

• Residues responsible for XMP binding and orientation

• Residues facilitating the formation of the adenyl-XMP intermediate

• Amino acids lining the ammonia channel

Interdomain region:

• Residues involved in conformational changes that coordinate the two catalytic activities

• Amino acids participating in allosteric communication between the two active sites

How can experimental research design address the mechanism of allosteric activation in E. coli GMPS?

To investigate the allosteric activation mechanism in E. coli GMPS, researchers could implement the following experimental design:

• Binding order determination:

  • Use isothermal titration calorimetry (ITC) to measure binding affinities of substrates in different orders

  • Perform steady-state kinetic studies with varied substrate concentrations to determine binding order and potential cooperativity

  • Employ stopped-flow spectroscopy to measure pre-steady-state kinetics and identify rate-limiting steps

• Conformational change monitoring:

  • Use FRET-based assays with strategically placed fluorophores to detect domain movements

  • Apply hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify regions that undergo conformational changes upon substrate binding

  • Utilize small-angle X-ray scattering (SAXS) to capture solution structures in different ligand-bound states

• Allosteric communication investigation:

  • Design domain-swapping experiments between GMPS enzymes from different species

  • Create chimeric constructs to identify key regions involved in allosteric communication

  • Perform molecular dynamics simulations to visualize potential allosteric pathways

• Mutational analysis:

  • Create a series of point mutations in residues suspected to be involved in the allosteric network

  • Measure the effects of these mutations on both GATase and ATPPase activities

  • Analyze how mutations affect substrate binding and catalytic efficiency

This comprehensive experimental approach could provide valuable insights into how binding of ATP- Mg2+ and XMP to the ATPPase domain allosterically activates the GATase domain, leading to glutamine binding and hydrolysis.

What are the key differences between E. coli GMPS and human GMPS that could be exploited for drug development?

Understanding the structural and functional differences between E. coli and human GMPS is crucial for developing selective inhibitors:

Researchers can exploit these differences by:

• Targeting the dimer interface of E. coli GMPS

• Designing inhibitors that exploit the differences in substrate binding order

• Focusing on non-conserved residues near the active site

• Developing compounds that disrupt the specific interdomain interactions in bacterial GMPS

This approach requires careful structural analysis and enzymatic characterization of both enzymes to identify exploitable differences.

How can recombinant E. coli GMPS be used as a model system for understanding catalytic mechanisms in the glutamine amidotransferase family?

E. coli GMPS serves as an excellent model system for studying the glutamine amidotransferase family for several reasons:

• Representative architecture: It contains the characteristic two-domain structure with a glutaminase domain and a synthase domain, connected by an ammonia channel .

• Experimental tractability: It can be expressed at high levels, purified to homogeneity, and is amenable to crystallization and structural analysis .

• Conserved catalytic features: It employs the same catalytic triad mechanism for glutamine hydrolysis and ammonia channeling as other family members.

Researchers can leverage E. coli GMPS to study:

• General principles of ammonia channeling in enzymes

• Allosteric communication between physically separated catalytic sites

• Coordination of two distinct chemical reactions

• Evolution of substrate specificity in the GAT family

Experimental approaches should include:

• Comparative structural and functional analyses with other GAT family members

• Investigation of conserved versus variable regions

• Chimeric enzyme construction to explore domain compatibility

• Site-directed mutagenesis of conserved residues to assess their roles

This research can provide insights into the catalytic mechanisms shared across the GAT family while highlighting the unique features that have evolved for specific metabolic functions.

What common challenges arise when expressing recombinant E. coli GMPS and how can they be addressed?

Researchers may encounter several challenges when expressing recombinant E. coli GMPS:

• Protein aggregation:

  • Problem: Formation of inclusion bodies during overexpression

  • Solution: Lower induction temperature (16-25°C), reduce IPTG concentration (0.1-0.5 mM), or use specialized E. coli strains (e.g., Arctic Express)

• Low expression levels:

  • Problem: Poor protein yield despite optimization

  • Solution: Codon optimization of the gene, use of a stronger promoter, or enriched media formulations

• Proteolytic degradation:

  • Problem: Multiple bands or smearing on SDS-PAGE

  • Solution: Add protease inhibitors during purification, use protease-deficient host strains, or optimize buffer conditions

• Loss of activity during purification:

  • Problem: Purified enzyme shows low or no activity

  • Solution: Include stabilizing agents (glycerol, reducing agents), avoid freeze-thaw cycles, or purify in the presence of substrates

• Oligomerization inconsistency:

  • Problem: Variable oligomeric states during purification

  • Solution: Standardize buffer conditions, control protein concentration, or add stabilizing ligands

For each challenge, experimental design should include appropriate controls and analytical methods to monitor protein quality throughout the expression and purification process.

How should researchers design kinetic experiments to analyze the bifunctional nature of E. coli GMPS?

To properly characterize the bifunctional nature of E. coli GMPS, researchers should implement a comprehensive kinetic analysis approach:

Data analysis should include fitting to appropriate kinetic models that account for the bifunctional nature of the enzyme and potential allosteric interactions between domains.

What methods are most effective for studying the ammonia channel in E. coli GMPS?

Investigating the ammonia channel in E. coli GMPS requires specialized techniques:

• Structural approaches:

  • High-resolution X-ray crystallography with substrate analogs or inhibitors to visualize the channel architecture

  • Cryo-electron microscopy to capture different conformational states

  • Molecular dynamics simulations to model ammonia movement through the channel

• Functional approaches:

  • 15N-labeled glutamine studies with NMR spectroscopy to track nitrogen transfer

  • Compare kinetics using glutamine versus direct ammonia supplementation to assess channeling efficiency

  • pH-dependence studies to determine the protonation state of channeled ammonia

• Mutagenesis strategies:

  • Create site-directed mutations of residues lining the putative channel

  • Introduce bulky side chains to create blockages at specific points

  • Engineer cysteine residues within the channel for disulfide crosslinking or chemical modification

• Spectroscopic methods:

  • Introduce fluorescent probes at strategic locations to monitor conformational changes

  • Use FRET pairs to measure domain movements associated with channel opening/closing

• Chemical biology approaches:

  • Design channel-specific inhibitors to block ammonia transfer

  • Utilize photoaffinity labeling to identify key residues involved in channel formation

These methods, used in combination, can provide complementary insights into the structure, dynamics, and function of the ammonia channel in E. coli GMPS.

What are the best approaches for comparing recombinant E. coli GMPS with GMPS from pathogenic bacteria for drug discovery purposes?

A systematic comparison of E. coli GMPS with GMPS from pathogenic bacteria should include:

• Structural comparison:

  • Determine crystal structures of GMPS from multiple pathogenic species

  • Perform detailed structural alignments to identify conserved and variable regions

  • Focus on active site architecture and potential druggable pockets unique to pathogenic species

• Enzymatic characterization:

  • Compare kinetic parameters (kcat, KM, substrate specificity) across species

  • Assess sensitivity to known inhibitors

  • Identify species-specific regulatory mechanisms

• Ligand binding analysis:

  • Use isothermal titration calorimetry (ITC) to measure binding affinities of substrates and inhibitors

  • Perform thermal shift assays to identify stabilizing ligands

  • Develop high-throughput screening assays specific for pathogenic GMPS

• Inhibitor design and testing:

  • Conduct structure-based virtual screening targeting unique features of pathogenic GMPS

  • Synthesize and test candidate inhibitors against panels of GMPS enzymes

  • Assess selectivity indices to identify compounds with preferential activity against pathogenic GMPS

• Cellular validation:

  • Test promising inhibitors in bacterial growth assays

  • Confirm target engagement in cellular contexts

  • Evaluate potential for resistance development

This comprehensive approach can identify exploitable differences between E. coli GMPS and pathogenic bacterial GMPS for selective inhibitor development.

How should researchers reconcile divergent kinetic data when studying E. coli GMPS?

When facing divergent kinetic data for E. coli GMPS, researchers should:

• Identify potential sources of variability:

  • Enzyme preparation methods (expression conditions, purification strategy)

  • Assay conditions (buffer composition, pH, temperature, ionic strength)

  • Substrate quality and preparation

  • Detection methods and their limitations

• Standardize experimental conditions:

  • Develop a rigorous protocol for enzyme preparation

  • Use consistent buffer conditions and substrate preparations

  • Implement multiple, complementary assay techniques

  • Include appropriate controls in each experiment

• Statistical analysis approaches:

  • Perform replicate measurements (minimum triplicate) for each condition

  • Apply appropriate statistical tests to assess significance of differences

  • Consider Bayesian approaches for integrating divergent datasets

  • Use global fitting procedures for complex kinetic models

• Reconciliation strategies:

  • Conduct side-by-side comparisons under identical conditions

  • Explore whether divergent results represent different enzyme states

  • Consider allosteric effects that might explain apparent discrepancies

  • Develop a unified kinetic model that accounts for all observations

• Reporting recommendations:

  • Provide detailed methods to ensure reproducibility

  • Report all experimental conditions that could affect outcomes

  • Present raw data alongside processed results

  • Discuss limitations and alternative interpretations

This systematic approach can help researchers resolve apparent contradictions and develop a more complete understanding of E. coli GMPS kinetics.

How can computational modeling enhance our understanding of E. coli GMPS structure-function relationships?

Computational approaches offer powerful tools for investigating E. coli GMPS:

• Molecular dynamics (MD) simulations:

  • Simulate protein dynamics to identify conformational changes during catalysis

  • Model substrate binding and product release

  • Investigate the ammonia channeling process

  • Explore allosteric communication between domains

• Quantum mechanics/molecular mechanics (QM/MM):

  • Model the chemical reaction mechanisms in both active sites

  • Calculate energy barriers for catalytic steps

  • Investigate the roles of specific residues in transition state stabilization

• Network analysis:

  • Identify allosteric communication pathways between domains

  • Analyze hydrogen bond networks and salt bridges important for structural integrity

  • Predict the effects of mutations on protein stability and function

• Docking and virtual screening:

  • Design and evaluate potential inhibitors

  • Identify novel binding sites for allosteric regulation

  • Predict binding modes of substrates and products

• Integration with experimental data:

  • Use experimental constraints to refine computational models

  • Design experiments to test computational predictions

  • Develop structure-activity relationships based on combined computational and experimental approaches

These computational approaches provide insights that may be difficult to obtain experimentally and can guide further experimental investigations of E. coli GMPS.

What are the implications of studying E. coli GMPS for understanding essential metabolic pathways in bacterial systems?

Research on E. coli GMPS has broader implications for bacterial metabolism:

• Nucleotide biosynthesis regulation:

  • Reveals how bacteria balance purine nucleotide pools

  • Identifies control points in de novo GMP synthesis

  • Elucidates connections between nucleotide metabolism and other cellular processes

• Metabolic network integration:

  • Demonstrates how glutamine metabolism interfaces with nucleotide synthesis

  • Highlights connections between energy metabolism (ATP) and nucleotide production

  • Reveals how bacteria coordinate nitrogen assimilation with nucleic acid synthesis

• Evolutionary conservation:

  • Provides insights into the conservation of essential metabolic enzymes across bacterial species

  • Identifies both highly conserved catalytic mechanisms and species-specific adaptations

  • Helps reconstruct the evolutionary history of purine biosynthesis pathways

• Drug target validation:

  • Confirms the essentiality of GMPS in bacterial growth and survival

  • Provides a molecular foundation for antibiotic development

  • Identifies potential resistance mechanisms that might emerge

• Metabolic engineering applications:

  • Suggests strategies for optimizing nucleotide production in biotechnology applications

  • Informs approaches for manipulating bacterial metabolism for synthetic biology goals

  • Provides templates for designing novel metabolic pathways

Understanding E. coli GMPS thus contributes to our broader knowledge of bacterial metabolism and offers practical applications in drug discovery, biotechnology, and synthetic biology.

What emerging technologies could advance our understanding of E. coli GMPS function and regulation?

Several cutting-edge technologies hold promise for deeper insights into E. coli GMPS:

• Cryo-electron microscopy (cryo-EM):

  • Capture conformational ensembles of GMPS in different functional states

  • Visualize dynamic processes during catalysis

  • Determine structures without crystallization, potentially revealing physiologically relevant conformations

• Time-resolved X-ray crystallography:

  • Monitor structural changes during catalysis in real-time

  • Capture transient intermediates in the reaction pathway

  • Provide dynamic views of the ammonia channeling process

• Single-molecule techniques:

  • Observe individual enzyme molecules during catalysis

  • Detect conformational dynamics and rare events

  • Correlate structural changes with catalytic steps

• Advanced NMR methods:

  • Characterize protein dynamics at atomic resolution

  • Study ligand binding and conformational changes in solution

  • Investigate allosteric communication pathways

• Integrative structural biology approaches:

  • Combine multiple techniques (X-ray, cryo-EM, NMR, SAXS) for comprehensive structural models

  • Resolve dynamic regions typically missing from crystal structures

  • Develop complete models of the catalytic cycle

• CRISPR-based technologies:

  • Create precise genomic modifications to study GMPS function in vivo

  • Develop conditional knockout systems to assess essentiality under different conditions

  • Implement CRISPRi for tunable repression to study dosage effects

These emerging technologies, especially when used in combination, promise to reveal new aspects of GMPS structure, dynamics, and function.

How might systems biology approaches enhance our understanding of E. coli GMPS in the context of cellular metabolism?

Systems biology offers powerful frameworks for studying E. coli GMPS within its broader metabolic context:

• Metabolic flux analysis:

  • Quantify how carbon and nitrogen flow through GMPS and connected pathways

  • Identify how GMPS activity influences global metabolic patterns

  • Determine how cells reroute metabolites when GMPS function is perturbed

• Multi-omics integration:

  • Combine transcriptomics, proteomics, and metabolomics data to build comprehensive models

  • Identify regulatory networks controlling GMPS expression and activity

  • Discover unexpected connections between GMPS and other cellular processes

• Genome-scale metabolic modeling:

  • Predict the systemic effects of GMPS inhibition or overexpression

  • Identify synthetic lethal interactions with GMPS

  • Simulate metabolic adaptations to changes in GMPS function

• Experimental evolution studies:

  • Track genetic changes that compensate for GMPS deficiencies

  • Identify potential resistance mechanisms to GMPS inhibitors

  • Discover novel regulatory interactions through adaptation to metabolic stress

• Network pharmacology approaches:

  • Predict off-target effects of GMPS inhibitors

  • Design multi-target strategies that enhance the efficacy of GMPS inhibition

  • Identify synergistic drug combinations targeting GMPS and connected pathways

These systems-level approaches can reveal how GMPS is integrated into cellular metabolism and regulation, providing a more comprehensive understanding than isolated biochemical studies.

What are the most promising areas for future research on E. coli GMPS?

Based on current knowledge and emerging technologies, several research directions hold particular promise:

• Dynamic structural studies: Investigating the conformational changes associated with substrate binding, catalysis, and product release using time-resolved techniques.

• Allosteric regulation mechanisms: Elucidating the molecular details of how ATP and XMP binding to the ATPPase domain activates the GATase domain.

• Ammonia channeling dynamics: Developing real-time methods to observe ammonia movement through the intramolecular tunnel.

• Targeted inhibitor development: Designing selective inhibitors that exploit structural and functional differences between bacterial and human GMPS.

• Integration with cellular metabolism: Understanding how GMPS activity is regulated in response to changing cellular demands for guanine nucleotides.

• Evolutionary analysis: Comparing GMPS across diverse species to understand how this essential enzyme has evolved while maintaining its core function.

• Post-translational modifications: Investigating whether bacterial GMPS is subject to regulatory modifications that modulate its activity under different conditions.